comparemela.com
Home
Live Updates
Enhance Allogeneic - Breaking News
Pages:
Latest Breaking News On - Enhance allogeneic - Page 1 : comparemela.com
Chroma Medicine Highlights Data Demonstrating Durable Multiplex Epigenetic Editing to Enhance Allogeneic CAR T at 65th ASH Annual Meeting
Chroma Medicine, Inc., (Chroma) a genomic medicine company pioneering single-dose epigenetic editing therapeutics, today presented data.
United states
San diego
Vic myer
Jamie schafer
Prnewswire chroma medicine inc
Vivo program sciences
American society of hematology
Enhance allogeneic
American society
Annual meeting
Durable multiplex epigenetic editing
Associate director
vimarsana © 2020. All Rights Reserved.